Evidence map›Paper›PMID 39177409›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2024

Canine RNF170 Single Base Deletion in a Naturally Occurring Model for Human Neuroaxonal Dystrophy.

Shawna R Cook, Cleo Schwarz, Julien Guevar, Charles-Antoine Assenmacher, Maeve Sheehy, Nathan Fanzone, Molly E Church, Leonardo Murgiano, Margret L Casal, Vidhya Jagannathan and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Integrative MRI and Genomics Analyses PrioritizeAnimals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Review
  4. Genes · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Shawna R CookDepartment of Basic Medical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.ORCID 0000-0001-7967-9607
Cleo SchwarzInstitute of Genetics, Vetsuisse Faculty, University of Bern, Bern, Switzerland.ORCID 0009-0006-7595-2817
Julien GuevarAniCura Thun, Neurology Department, Burgerstrasse, Switzerland.ORCID 0000-0001-9868-5703
Charles-Antoine AssenmacherDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-0073-2730
Maeve SheehyDepartment of Basic Medical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.ORCID 0009-0004-1620-0514
Nathan FanzoneDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0009-0002-8139-7523
Molly E ChurchDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-4819-3038
Leonardo MurgianoDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-3539-9344
Margret L CasalDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-1224-6708
Vidhya JagannathanInstitute of Genetics, Vetsuisse Faculty, University of Bern, Bern, Switzerland.ORCID 0000-0002-8155-0041
Rodrigo Gutierrez-QuintanaSmall Animal Hospital, School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, UK.ORCID 0000-0002-3570-2542
Mark LowrieMovement Referrals: Independent Veterinary Specialists, Preston Brook, UK.ORCID 0000-0002-4993-589X
Frank SteffenNeurology Service, Department of Small Animals, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID 0009-0007-0383-1423
Tosso LeebInstitute of Genetics, Vetsuisse Faculty, University of Bern, Bern, Switzerland.ORCID 0000-0003-0553-4880
Kari J EkenstedtDepartment of Basic Medical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.ORCID 0000-0002-3213-7883

Funding

Novel Genetic Models for Vertebral AbnormalitiesK01OD027051 · OD · PURDUE UNIVERSITY · PI EKENSTEDT, KARI J · 2019 to 2023
$627k
NIH HHS K01 OD027051NIH Office of the Director K01OD027051Van Sloun Fund for Canine Genetic Research
6 · The paper itself

Abstract

backgroundNeuroaxonal dystrophy (NAD) is a group of inherited neurodegenerative disorders characterized primarily by the presence of spheroids (swollen axons) throughout the central nervous system. In humans, NAD is heterogeneous, both clinically and genetically. NAD has also been described to naturally occur in large animal models, such as dogs. A newly recognized disorder in Miniature American Shepherd dogs (MAS), consisting of a slowly progressive neurodegenerative syndrome, was diagnosed as NAD via histopathology.

objectivesTo describe the clinical and pathological phenotype together with the identification of the underlying genetic cause.

methodsClinical and postmortem evaluations, together with a genome-wide association study and autozygosity mapping approach, followed by whole-genome sequencing.

resultsAffected dogs were typically young adults and displayed an abnormal gait characterized by pelvic limb weakness and ataxia. The underlying genetic cause was identified as a 1-bp (base pair) deletion in RNF170 encoding ring finger protein 170, which perfectly segregates in an autosomal recessive pattern. This deletion is predicted to create a frameshift (XM_038559916.1:c.367delG) and early truncation of the RNF170 protein (XP_038415844.1:(p.Ala123Glnfs*11)). The age of this canine RNF170 variant was estimated at ~30 years, before the reproductive isolation of the MAS breed.

conclusionsRNF170 variants were previously identified in human patients with autosomal recessive spastic paraplegia-85 (SPG85); this clinical phenotype shows similarities to the dogs described herein. We therefore propose that this novel MAS NAD could serve as an excellent large animal model for equivalent human diseases, particularly since affected dogs demonstrate a relatively long lifespan, which represents an opportunity for therapeutic trials. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Disease Models, AnimalNeuroaxonal DystrophiesAnimalsDog DiseasesDogsFemaleGenome-Wide Association StudyHumansMaleSequence DeletionUbiquitin-Protein LigasesUbiquitin-Protein Ligasesanimal modelhereditary sensory ataxia 1hereditary spastic paraplegiaMiniature American Shepherdspheroids

Identifiers

PMID39177409
PMCPMC13281964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.